Robeco Institutional Asset Management’s Medline Inc MDLN Stock Holding History

Robeco Institutional Asset Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.2M	Buy	+1,626,993	New	+$65.6M	0.08%	236

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Robeco Institutional Asset Management's MDLN Position: Q2 2026 in Review

Robeco Institutional Asset Management opened a new position in Medline Inc (MDLN) in Q2 2026: 1,626,993 shares worth $64.2M. The stake represents 0.08% of the portfolio and ranks #236 among its holdings.

409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Robeco Institutional Asset Management held 1,626,993 shares of Medline Inc worth $64.2M as of Q2 2026.
Medline Inc was a new Robeco Institutional Asset Management position in Q2 2026.
Medline Inc made up 0.08% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #236 holding.
409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.